Customer engagement and pharma’s field force futureHow healthcare professionals (HCPs) prefer to engage with pharma companies has been changing for some time, and COVID’s Share XCustomer engagement and pharma’s field force futurehttps://pharmaphorum.com/webinars/axtria-customer-engagement-pharmas-field-force-future-digital-transformation/
AI, big data and deep real-world evidence – the challenges and opportunitiesReal-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights Share XAI, big data and deep real-world evidence – the challenges and opportunitieshttps://pharmaphorum.com/webinars/ai-big-data-real-world-evidence-savana/
Virtual trials and the next generation of pharma clinical researchPreviously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a Share XVirtual trials and the next generation of pharma clinical researchhttps://pharmaphorum.com/webinars/nihr-virtual-trials-pharma-research/
Coordinating and delivering research in the pandemic: The UK approachThe acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical Share XCoordinating and delivering research in the pandemic: The UK approachhttps://pharmaphorum.com/webinars/uk-covid-coronavirus-research-nihr/
Increasing patient engagement with UK clinical trialsPharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so Share XIncreasing patient engagement with UK clinical trialshttps://pharmaphorum.com/webinars/uk-regulatory-pathway-patient-engagement-trials/
Introducing the new NIHR National Patient Recruitment CentresThe five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical Share XIntroducing the new NIHR National Patient Recruitment Centreshttps://pharmaphorum.com/webinars/nihr-national-patient-recruitment-centres/
Vaccines trials in the COVID-19 era and tech’s role in speeding studiesOverview The COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus Share XVaccines trials in the COVID-19 era and tech’s role in speeding studieshttps://pharmaphorum.com/r-d/vaccines-trials-covid-19-coronavirus/
The COVID-19 coronavirus and pharma and biotech continuity planningOverview Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from Share XThe COVID-19 coronavirus and pharma and biotech continuity planninghttps://pharmaphorum.com/r-d/the-potential-impact-of-coronavirus-covid-19-for-global-pharma-and-biotech-continuity/
Navigating new frontiers: Ways to find space in the future RA marketOverview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 Share XNavigating new frontiers: Ways to find space in the future RA markethttps://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/
